| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.41M | - | |
| Other | 67.7K | $2.46M | - | |
| CFO | 40.3K | $1.46M | - | |
| Other | 37.7K | $1.37M | - | |
| Other | 34.6K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2015 | Schenkein David P59 | Chief Executive Officer | Sell | 13,000 | $120.67 | $1,568,710.00 | -4.0% | |
| Jun 1, 2015 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 5,000 | $120.67 | $603,350.00 | -100% | |
| May 27, 2015 | Goddard Glenn83 | Senior Vice President, Finance | Sale+OE | 2,171 | $120.05 | $260,628.55 | -100% | |
| May 27, 2015 | Schenkein David P59 | Chief Executive Officer | Sell | 8,929 | $120.05 | $1,071,926.45 | -9.4% | |
| May 20, 2015 | Cantley Lewis Clayton Jr. | Director | Sell | 9,704 | $116.64 | $1,131,850.30 | -1.4% | |
| May 15, 2015 | Higgons John Duncan | Chief Operating Officer | Sell | 7,417 | $112.89 | $837,305.13 | -7.0% | |
| May 12, 2015 | Schenkein David P | Chief Executive Officer | Sell | 5,200 | $110.02 | $572,093.86 | -2.6% | |
| May 8, 2015 | Schenkein David P | Chief Executive Officer | Sale+OE | 3,900 | $101.32 | $395,148.00 | -1.1% | |
| May 7, 2015 | Biller Scott | Chief Scientific Officer | Sell | 11,000 | $96.98 | $1,066,780.00 | -13.0% | |
| May 1, 2015 | Schenkein David P | Chief Executive Officer | Sell | 3,900 | $93.63 | $365,157.00 | -1.7% |